Nutex Health, Inc. (NUTX)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$193.24-2.25%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · NUTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 846.7 | 875.3 | 479.9 | 247.6 | 219.3 | 331.5 | 274.0 | 1.4 | 1.4 | 0.0 | — | 0.5 | 1.1 | 1.5 | 1.6 | 1.8 |
| Total Revenues | 846.7 | 875.3 | 479.9 | 247.6 | 219.3 | 331.5 | 274.0 | 1.4 | 1.4 | 0.0 | — | 0.5 | 1.1 | 1.5 | 1.6 | 1.8 |
| Cost of Revenues | — | — | — | — | — | 14.6 | 0.9 | 0.8 | 0.5 | 0.0 | — | 0.0 | 0.5 | 0.5 | 0.8 | 0.8 |
| Gross Profit | 434.0 | 444.3 | 196.3 | 34.8 | 15.4 | 179.3 | 157.6 | 0.5 | 0.9 | (0.0) | — | 0.5 | 0.6 | 1.0 | 0.8 | 1.0 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | — | — | — | — | — | 0.3 | 0.6 | 0.8 | — | — | — | — | — | — | — | — |
| Operating Income | 364.3 | 275.6 | 130.6 | (31.8) | (406.6) | 170.3 | 153.2 | (6.9) | (0.8) | (5.7) | (0.4) | (0.5) | (0.7) | (0.7) | (1.6) | (0.8) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | 22.2 | 19.9 | 16.3 | 12.5 | 6.2 | 6.4 | 0.1 | 0.1 | 0.4 | 0.0 | (0.0) | (0.0) | (0.1) | — | — |
| Interest & Investment Income | — | — | — | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — |
| Net Interest Expenses | — | — | — | — | — | 6.2 | 6.4 | 0.1 | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | — | — | (0.0) | (0.0) | 0.1 | 0.7 | 0.0 | — |
| Asset Writedown | — | — | 3.9 | 29.1 | 398.1 | — | 3.5 | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 343.5 | 244.8 | 109.7 | (48.5) | (419.6) | 169.5 | 145.7 | — | — | — | — | (0.5) | (0.6) | (0.1) | (1.5) | (0.8) |
| Income Tax Expense | 71.0 | 64.4 | 14.5 | (5.1) | 13.1 | 1.0 | 0.2 | 0.0 | — | — | — | — | — | — | — | — |
| Earnings from Continuing Operations | — | — | — | — | — | 13.7 | 5.5 | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | 92.6 | 109.6 | 43.1 | 2.4 | (8.0) | 35.9 | 39.6 | — | — | — | — | — | — | — | — | — |
| Net Income | 179.9 | 70.8 | 52.2 | (45.8) | (424.8) | 132.6 | 106.0 | (7.1) | (1.0) | 0.6 | (7.4) | 0.1 | (0.7) | 0.3 | (1.6) | (0.4) |
| Per Share | ||||||||||||||||
| Basic EPS | 26.19 | 11.13 | 10.25 | (10.39) | (100.36) | 0.22 | 0.18 | — | — | — | — | — | — | — | — | — |
| Diluted EPS | 25.62 | 10.48 | 9.71 | (10.39) | (100.36) | 0.22 | 0.18 | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 120.59 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 6.9 | 6.4 | 5.1 | 4.4 | 4.2 | 592.8 | 592.8 | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 7.0 | 6.8 | 5.4 | 4.4 | 4.2 | — | — | — | — | — | 39.7 | 29.2 | 25.9 | 26.0 | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | 296.2 | 149.6 | (14.2) | (393.5) | 177.9 | 159.1 | (6.7) | — | — | — | (0.5) | (0.7) | (0.7) | — | — |
| EBIT | 364.3 | 275.6 | 130.6 | (31.8) | (406.6) | 170.3 | 153.2 | (6.9) | (0.8) | (5.7) | (0.4) | (0.5) | (0.7) | (0.7) | (1.6) | (0.8) |
| Effective Tax Rate | 20.7% | — | — | 10.4% | -3.1% | 0.6% | 0.1% | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.